Contract sales & marketing

Pharma industry, CROs adapting to COVID-19 impacts: survey

27-Jul-2021 By Jenni Spinner

A recent check-in with several biopharma and CRO companies, conducted by Life Science Strategy Group, indicates adjustment to pandemic-related challenges.

Contract data analysis can help predict pharma demand: Agiloft

19-Jul-2021 By Jenni Spinner

The process management solutions firm says drug companies could use contract data to get a better handle on predicting demand and adjusting product output.

People on the Move: July 2021

08-Jul-2021 By Jenni Spinner

This month’s news on hires, promotions, acquisitions, and expansions includes items about Javara, Elligo, Lonza, Yourway, Medable, and other notable firms.

FDA issues guidance for measuring PROs in oncology studies

17-Jun-2021 By Jenni Spinner

The US federal agency has released a document designed to help clinical trial teams obtain effective, efficient data from patients in their cancer research.

Azzur opens new on-demand cleanroom facility in California

03-Jun-2021 By Jenni Spinner

The company’s Azzur Cleanrooms on Demand division has established another facility in Vista, a city in the San Diego Area, for life-sciences operations.

People on the Move: June 2021

02-Jun-2021 By Jenni Spinner

This month’s roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.

Finding the right partners key to decentralized trials: Illingworth

03-May-2021 By Jenni Spinner

A leader from the mobile research nursing specialist offers advice on what to look for in a service provider, and why finding the right one is vital.

CPhI survey: pharma leaders optimistic about the future

03-May-2021 By Jenni Spinner

According to a recent survey of executives conducted by CPhI, COVID-19’s impact is driving manufacturing and CDMOs are fueling industry growth.

Severe winter storm wrought havoc on pharma supply chain

08-Apr-2021 By Jenni Spinner

An expert from FourKites shares impacts of the February storm that hit Texas and other parts of North America, and lessons can be learned from the event.

ICON to acquire PRA Health Sciences in $12b deal

25-Feb-2021 By Jenni Spinner

The deal consolidates two significant players in the contract research organization arena, in a deal reportedly worth approximately $12b USD.

Eversana, Evoke Pharma partner on nasal drug for patients with diabetic gastroparesis

10-Nov-2020 By Jenni Spinner

The two companies have joined forces to collaborate on the commercial launch of Gimoti, a nasal spray for patients suffering from diabetic gastroparesis.

Syneos Health to acquire Synteract

29-Oct-2020 By Jenni Spinner

With the purchase, Syneos Health seeks to strengthen connections with the rapidly growing pre-revenue biopharmaceutical market, and expand global reach.